↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

252 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   (+)-(s)-2-(6-methoxynaphthalen-2-yl) propanoic acid   Propanoic acid   D02310   -   -   1件:
271 
 2   0881   -   -   -   -   2件:
46,
271 
 3   150 mg double-blinded secukinumab   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
271 
 4   150 mg open-label secukinumab   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
271 
 5   300 mg double-blinded secukinumab   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
271 
 6   40 mg msb11022   -   -   -   -   4件:
46,
96,
97,
271 
 7   42942019   -   -   -   -   4件:
46,
96,
97,
271 
 8   5-chlor-6'-methyl- 3-[4-(methylsulfonyl)phenyl]- 2,3'-bipyridin   Chlorine   -   -   -   2件:
46,
271 
 9   5057732   -   -   -   -   1件:
271 
 10   99mtc-rhannexin v-128   -   -   -   -   2件:
46,
271 
 11   [18f]fluoride   -   -   -   -   1件:
271 
 12   Abatacept   Abatacept   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 13   Acetaminophen   Acetaminophen   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   11件:
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271 
 14   Aclasta   Zoledronic acid   D01968, D06378, D06379, D08689   1件: FDPS   1件: Terpenoid backbone biosynthesis   3件:
13,
271,
274 
 15   Adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 16   Adalimumab (d2e7)   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
271 
 17   Adalimumab (humira)   Adalimumab, Isopropyl alcohol   D00137, D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
222,
271 
 18   Adalimumab 40 mg sc every other week   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 19   Adalimumab, etanercept, golimumab or infliximab   Adalimumab, Etanercept, Golimumab, Infliximab   D00742, D02597, D02598, D04358   2件: LTA, TNF   12件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 20   Ain457   -   -   -   -   7件:
13,
37,
41,
46,
56,
96,
271 
 21   Ain457/secukinumab   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
271 
 22   Alendronate   Alendronic acid   D00939, D07119   1件: FDPS   1件: Terpenoid backbone biosynthesis   7件:
19,
41,
46,
50,
271,
274,
299 
 23   Anti tnf alpha agent   -   -   -   -   1件:
271 
 24   Anti tnf alpha therapy   -   -   -   -   1件:
271 
 25   Anti-(human tumor necrosis factor) immunoglobulin g (human-mouse monoclonal ca2 heavy chain)   -   -   -   -   1件:
271 
 26   Anti-human interleukin-23 monoclonal antibody   -   -   -   -   1件:
271 
 27   Anti-tnf   -   -   -   -   3件:
46,
96,
271 
 28   Anti-tnf biologics   -   -   -   -   2件:
46,
271 
 29   Anti-tnf therapy (etanercept or adalimumab)   Adalimumab, Etanercept   D00742, D02597   2件: LTA, TNF   11件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 30   Anti-tumor necrosis factor   -   -   -   -   1件:
271 
 31   Apremilast   Apremilast   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   2件: Purine metabolism, cAMP signaling pathway   5件:
46,
50,
56,
97,
271 
 32   Apremilast tablet 20 mg   Apremilast   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   2件: Purine metabolism, cAMP signaling pathway   1件:
271 
 33   Apremilast tablet 30 mg bid   Apremilast   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   2件: Purine metabolism, cAMP signaling pathway   1件:
271 
 34   Arcoxia   -   -   -   -   2件:
46,
271 
 35   Arcoxia 90 mg comprimidos recubiertos con película   -   -   -   -   1件:
271 
 36   Arry-371797   -   -   -   -   1件:
271 
 37   Arry-371797, p38 inhibitor   -   -   -   -   2件:
46,
271 
 38   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 39   Bat1406   -   -   -   -   1件:
271 
 40   Bcd-055   -   -   -   -   2件:
46,
271 
 41   Bcd-085   -   -   -   -   2件:
93,
271 
 42   Bdmard treatment   -   -   -   -   1件:
271 
 43   Benepali   -   -   -   -   2件:
46,
271 
 44   Bi 655066   -   -   -   -   2件:
96,
271 
 45   Bi 655066 90 mg/ml   -   -   -   -   2件:
96,
271 
 46   Bimekizumab   Bimekizumab   D11550   2件: IL17A, IL17F   2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway   3件:
46,
97,
271 
 47   Biologic dmard   -   -   -   -   2件:
46,
271 
 48   Biosimilar   -   -   -   -   4件:
46,
96,
97,
271 
 49   Blood collection   -   -   -   -   1件:
271 
 50   Blood samples   -   -   -   -   8件:
13,
41,
46,
51,
61,
97,
227,
271 
 51   Bms-188667   bms-188667   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   6件:
46,
49,
65,
96,
97,
271 
 52   Bms-986251   -   -   -   -   2件:
46,
271 
 53   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 54   Cannabidiol tablet 10 mg   Cannabidiol   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   2件:
46,
271 
 55   Cc-10004   -   -   -   -   2件:
56,
271 
 56   Cdp870   cdp870   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   3件:
46,
96,
271 
 57   Celebrex   Celecoxib   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   3件:
46,
96,
271 
 58   Celecoxib   Celecoxib   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   8件:
2,
3,
34,
46,
70,
89,
161,
271 
 59   Celecoxib 200 milligrams   Celecoxib   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 60   Celecoxib 400 milligrams   Celecoxib   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 61   Celecoxib, celebrex®   Celecoxib   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 62   Certolizumab   -   -   -   -   3件:
46,
96,
271 
 63   Certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   6件:
37,
46,
96,
97,
226,
271 
 64   Certolizumab pegol (czp)   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   3件:
46,
96,
271 
 65   Chlor   Chlorine   -   -   -   2件:
46,
271 
 66   Cimzia   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   4件:
46,
96,
97,
271 
 67   Cimzia certolizumab pegol 200 mg/ml solution for injection   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   1件:
271 
 68   Cimzia®   -   -   -   -   2件:
46,
271 
 69   Cnto 148   -   -   -   -   3件:
46,
84,
271 
 70   Cosentyx   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   3件:
41,
269,
271 
 71   Cp-690,550   -   -   -   -   4件:
46,
96,
97,
271 
 72   Ct-p13   -   -   -   -   4件:
46,
96,
97,
271 
 73   Ctla4ig   -   -   -   -   4件:
46,
49,
96,
271 
 74   Diclofenac   Diclofenac   D00903, D00904, D07816   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   4件:
13,
34,
46,
271 
 75   Diclofenac 50 milligrams   Diclofenac   D00903, D00904, D07816   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 76   Diclofenac sr   Diclofenac   D00903, D00904, D07816   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 77   Dmards   -   -   -   -   2件:
46,
271 
 78   Dronabinol   Dronabinol   D00306   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   5件:
2,
13,
46,
271,
298 
 79   Dronabinol capsule 2.5. mg   Dronabinol   D00306   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   2件:
46,
271 
 80   Drug treatment   -   -   -   -   3件:
51,
74,
271 
 81   E-device   -   -   -   -   3件:
46,
96,
271 
 82   Enbrel   Water   D00001   -   -   3件:
28,
46,
271 
 83   Enbrel (etanercept)   Water, Etanercept   D00001, D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
35,
46,
271 
 84   Enbrel plus celebrex   Celecoxib, Water   D00001, D00567   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 85   Enbrel®   -   -   -   -   2件:
46,
271 
 86   Enia11   -   -   -   -   2件:
46,
271 
 87   Entecavir   Entecavir   D04008, D07896   -   -   5件:
46,
56,
96,
97,
271 
 88   Etanercept   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   14件:
15,
35,
38,
39,
46,
50,
53,
56,
60,
85,
228,
271,
285,
298 
 89   Etanercept (50mg per week)   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 90   Etanercept (50mg per week, for 2 weeks)   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 91   Etanercept (50mg per week, for 4 weeks)   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 92   Etanercept (enbrel)   Water, Etanercept   D00001, D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 93   Etanercept (full-dose)   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 94   Etanercept (half-dose)   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 95   Etoricoxib   Etoricoxib   D03710   1件: PTGS2   1件: Arachidonic acid metabolism   2件:
46,
271 
 96   Fengshigutong capsule   -   -   -   -   1件:
271 
 97   Fengshigutong capsule plus imrecoxib   Imrecoxib   -   -   -   1件:
271 
 98   Filgotinib   Filgotinib   D10871   1件: JAK1   3件: JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   6件:
46,
53,
96,
97,
222,
271 
 99   Focetria (monovalent mf59-adjuvanted vaccine)   -   -   -   -   3件:
46,
49,
271 
 100   Glpg0634   -   -   -   -   3件:
46,
96,
271 
 101   Glucosamine   Glucosamine   D04334   -   -   2件:
46,
271 
 102   Golimumab   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   5件:
46,
84,
96,
97,
271 
 103   Golimumab (cnto 148)   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 104   Golimumab injection   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 105   Golimumab liquid in vial   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 106   Golimumab pre-filled syringe   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 107   Gp2017   -   -   -   -   2件:
46,
271 
 108   Gp2017 (adalimumab biosimilar)   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 109   Herpes zoster vaccine   -   -   -   -   3件:
46,
96,
271 
 110   Human anti-tnf igg1 monoclonal antibody   -   -   -   -   2件:
46,
271 
 111   Human anti-tnfalfa   -   -   -   -   2件:
46,
271 
 112   Human umbilical cord-derived mscs   -   -   -   -   1件:
271 
 113   Humira   Isopropyl alcohol   D00137   -   -   6件:
46,
84,
96,
97,
269,
271 
 114   Humira®   -   -   -   -   4件:
46,
96,
97,
271 
 115   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 116   Ibi303   -   -   -   -   1件:
271 
 117   Ibuprofen   Ibuprofen   D00126, D01122, D04490, D06606   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   6件:
13,
46,
65,
113,
271,
299 
 118   Iguratimod   Iguratimod   D01146   1件: NFKB1   2件: NF-kappa B signaling pathway, Osteoclast differentiation   3件:
46,
53,
271 
 119   Imrecoxib   Imrecoxib   -   -   -   1件:
271 
 120   Indomethacin   Indometacin   D00141, D01565, D02110   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   2件:
225,
271 
 121   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 122   Infliximab (bcd-055)   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 123   Infliximab (remicade)   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
96,
271 
 124   Infliximab and mtx   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 125   Interleukin 2   Human interleukin-2, interleukin 2   -   -   -   9件:
46,
49,
51,
56,
63,
95,
96,
97,
271 
 126   Intravenous infusion of mscs   -   -   -   -   1件:
271 
 127   Ixekizumab   Ixekizumab   D10071   1件: IL17A   2件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway   4件:
37,
162,
269,
271 
 128   Kunxian capsule   -   -   -   -   2件:
46,
271 
 129   L04aa24   -   -   -   -   2件:
46,
271 
 130   L04ab01   -   -   -   -   2件:
46,
271 
 131   L04ab04   -   -   -   -   2件:
46,
271 
 132   L04ab05   -   -   -   -   2件:
46,
271 
 133   L04ab06   -   -   -   -   2件:
46,
271 
 134   Leflunomide   Leflunomide   D00749   1件: DHODH   1件: Pyrimidine metabolism   9件:
11,
40,
46,
49,
53,
66,
224,
271,
300 
 135   Loxoprofen   Loxoprofen   D08149   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   2件:
46,
271 
 136   Loxoprofen sodium hydrogel patch   Loxoprofen   D08149   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 137   Loxoprofen sodium tablet   Loxoprofen   D08149   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 138   Ly2439821   -   -   -   -   2件:
46,
271 
 139   Mabthera   -   -   -   -   15件:
11,
13,
35,
46,
50,
51,
53,
61,
63,
64,
65,
83,
162,
222,
271 
 140   Mabthera 500   -   -   -   -   1件:
271 
 141   Meloxicam   Meloxicam   D00969   1件: PTGS2   1件: Arachidonic acid metabolism   4件:
46,
49,
271,
296 
 142   Meloxicam suppository   Meloxicam   D00969   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 143   Meloxicam tablet   Meloxicam   D00969   1件: PTGS2   1件: Arachidonic acid metabolism   2件:
46,
271 
 144   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 145   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 146   Misoprostol   Misoprostol   D00419   3件: PTGER2, PTGER3, PTGER4   3件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, cAMP signaling pathway   2件:
46,
271 
 147   Mk-0663   mk-0663   D03710   1件: PTGS2   1件: Arachidonic acid metabolism   2件:
46,
271 
 148   Mk-3222   -   -   -   -   1件:
271 
 149   Monoclonal antibody (mab)   -   -   -   -   1件:
271 
 150   Méthotrexate   -   -   -   -   1件:
271 
 151   Méthotrexate bellon comprimé   -   -   -   -   1件:
271 
 152   Nanocurcumin   -   -   -   -   2件:
13,
271 
 153   Naprosyn   Naproxen   D00118   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 154   Naprosysn   -   -   -   -   1件:
271 
 155   Naproxen   Naproxen   D00118   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   3件:
13,
46,
271 
 156   Naproxen 500 mg tablets (pn 200 minus omeprazole)   Naproxen, Omeprazole   D00118, D00455, D01207, D05259, D05261   4件: ATP4A, ATP4B, PTGS1, PTGS2   3件: Arachidonic acid metabolism, Collecting duct acid secretion, Gastric acid secretion   2件:
46,
271 
 157   Non-anti-tnf biologics   -   -   -   -   2件:
46,
271 
 158   Nsaids   -   -   -   -   4件:
46,
70,
107,
271 
 159   Nsaids and sulfasalazine   Sulfasalazine   D00448   -   -   1件:
271 
 160   Nsnsaids   -   -   -   -   1件:
271 
 161   Null   -   -   -   -   17件:
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 162   Olsalazine   Olsalazine   D00727, D08295   -   -   1件:
271 
 163   Omeprazole   Omeprazole   D00455, D01207, D05259, D05261   2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299 
 164   Orencia   Abatacept   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   9件:
46,
50,
51,
53,
65,
84,
96,
97,
271 
 165   Originator   -   -   -   -   2件:
46,
271 
 166   Originator (legacy) drug   -   -   -   -   4件:
46,
96,
97,
271 
 167   Other cox-2 inhibitor   -   -   -   -   1件:
271 
 168   Other cox-2 inhibitors   -   -   -   -   1件:
271 
 169   Other non-selective nsaids   -   -   -   -   1件:
271 
 170   Pamidronate   Pamidronic acid   D00941, D07281   1件: FDPS   1件: Terpenoid backbone biosynthesis   2件:
271,
274 
 171   Parecoxib   Parecoxib   D02709, D03716   1件: PTGS2   1件: Arachidonic acid metabolism   2件:
46,
271 
 172   Part i - etoricoxib 60 mg   Etoricoxib   D03710   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 173   Part i - etoricoxib 90 mg   Etoricoxib   D03710   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 174   Part i- naproxen 1000 mg   Naproxen   D00118   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 175   Part ii- etoricoxib 60 mg   Etoricoxib   D03710   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 176   Part ii- etoricoxib 90 mg   Etoricoxib   D03710   1件: PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 177   Part ii- naproxen 1000 mg   Naproxen   D00118   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 178   Pn 200 tablets (500 mg naproxen and 20 mg omeprazole)   Naproxen, Omeprazole   D00118, D00455, D01207, D05259, D05261   4件: ATP4A, ATP4B, PTGS1, PTGS2   3件: Arachidonic acid metabolism, Collecting duct acid secretion, Gastric acid secretion   2件:
46,
271 
 179   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 180   Propanoic acid   Propanoic acid   D02310   -   -   1件:
271 
 181   Rebamipide   Rebamipide   D01121   -   -   4件:
46,
53,
97,
271 
 182   Recombinant human monoclonal antibody to il-17 of the igg1-k-class   -   -   -   -   1件:
271 
 183   Recombinant tnf-a receptor: igg fc fusion protein   -   -   -   -   2件:
46,
271 
 184   Remicade   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   8件:
46,
49,
56,
84,
85,
96,
97,
271 
 185   Remicade 100 mg polvo para concentrado para solución para perfusión   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 186   Remicade®   -   -   -   -   2件:
46,
271 
 187   Remsima   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   4件:
46,
96,
97,
271 
 188   Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   4件:
46,
96,
97,
271 
 189   Rhutnfr   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 190   Rhutnfr:fc   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 191   Risankizumab   Risankizumab   D11052   1件: IL23A   3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Th17 cell differentiation   4件:
37,
96,
97,
271 
 192   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 193   Rituximab/ mabthera   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
271 
 194   Ro 487-533/f01   -   -   -   -   1件:
271 
 195   Ro 487-5733/f01   -   -   -   -   1件:
271 
 196   Ro45-2294   -   -   -   -   1件:
271 
 197   Roactemra®   -   -   -   -   2件:
46,
271 
 198   Rosuvastatin   Rosuvastatin   D01915, D08492   1件: HMGCR   1件: Terpenoid backbone biosynthesis   8件:
6,
46,
49,
51,
79,
96,
271,
299 
 199   Rtnv148b igg   -   -   -   -   2件:
46,
271 
 200   Salazopyrin en-tabs   -   -   -   -   2件:
46,
271 
 201   Salicylazosulfapyridine   Sulfasalazine   D00448   -   -   1件:
271 
 202   Sar153191   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   4件:
41,
46,
107,
271 
 203   Sb4 (etanercept biosimilar)   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 204   Secukinumab   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   7件:
13,
37,
41,
46,
160,
269,
271 
 205   Secukinumab (150 mg)   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
271 
 206   Secukinumab (75 mg)   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
271 
 207   Secukinumab 150 milligram [cosentyx]   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   1件:
271 
 208   Secukinumab 150mg   Secukinumab   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   2件:
37,
271 
 209   Simponi   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
97,
271 
 210   Simponi®   -   -   -   -   2件:
46,
271 
 211   Sulfasalazine   Sulfasalazine   D00448   -   -   3件:
46,
94,
271 
 212   Sulfasalazine, ssz   Sulfasalazine   D00448   -   -   1件:
271 
 213   Sulphasalazine   sulphasalazine   D00448   -   -   2件:
46,
271 
 214   Sulphasalazine (ssz)   sulphasalazine   D00448   -   -   1件:
271 
 215   Sulphasalazine 500 mg en-tabs   sulphasalazine   D00448   -   -   1件:
271 
 216   Sunpg1622 i dose   -   -   -   -   1件:
271 
 217   Systemic non-biological treatments   -   -   -   -   2件:
46,
271 
 218   Ta-650 (infliximab)   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
97,
271 
 219   Tapering or discontinuation of etanercept   Etanercept   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 220   Thalidomide   Thalidomide   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331 
 221   Thalidomide 100mg   Thalidomide   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   1件:
271 
 222   Thalidomide 150mg   Thalidomide   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   1件:
271 
 223   Tildrakizumab   Tildrakizumab   D10400   1件: IL23A   1件: Cytokine-cytokine receptor interaction   1件:
271 
 224   Tildrakizumab 100 mg (one 1-ml injection of 100 mg/ml   Tildrakizumab   D10400   1件: IL23A   1件: Cytokine-cytokine receptor interaction   1件:
271 
 225   Tildrakizumab 100 mg/ml   Tildrakizumab   D10400   1件: IL23A   1件: Cytokine-cytokine receptor interaction   1件:
271 
 226   Tildrakizumab 200 mg (two 1-ml injections of 100 mg/ml)   Tildrakizumab   D10400   1件: IL23A   1件: Cytokine-cytokine receptor interaction   1件:
271 
 227   Tnf alpha   -   -   -   -   1件:
271 
 228   Tnf blockers (infliximab, adalimumab, etanercept)   Adalimumab, Etanercept, Infliximab   D00742, D02597, D02598   2件: LTA, TNF   11件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 229   Tnf-a antagonists, non-tnfs, dmard non-biologics   -   -   -   -   2件:
46,
271 
 230   Tnf-alpha antagonists   -   -   -   -   3件:
46,
96,
271 
 231   Tnf-inhibition   -   -   -   -   1件:
271 
 232   Tnfr:fc   -   -   -   -   2件:
46,
271 
 233   Tnr-001   tnr-001   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
271 
 234   Tnr-001, tnfr:fc   tnr-001   D00742   2件: LTA, TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
271 
 235   Tocilizumab   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331 
 236   Tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   9件:
46,
49,
50,
51,
84,
96,
97,
107,
271 
 237   Tofacitinib 10 mg   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   1件:
271 
 238   Tofacitinib 2 mg   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   1件:
271 
 239   Tofacitinib 5 mg   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   2件:
46,
271 
 240   Tofacitinib citrate   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   3件:
46,
49,
271 
 241   Total glucosides paeony capsules   -   -   -   -   1件:
271 
 242   Tramadol   Tramadol   D01355, D08623   1件: OPRM1   1件: Neuroactive ligand-receptor interaction   5件:
46,
70,
78,
226,
271 
 243   Tramadol /acetaminophen   Acetaminophen, Tramadol   D00217, D01355, D08623   3件: OPRM1, PTGS1, PTGS2   2件: Arachidonic acid metabolism, Neuroactive ligand-receptor interaction   1件:
271 
 244   Tripterygium   Tripterygium wilfordii whole   -   -   -   8件:
46,
66,
67,
96,
162,
222,
224,
271 
 245   Tripterygium wilfordii   Tripterygium wilfordii whole   -   -   -   6件:
46,
66,
67,
222,
224,
271 
 246   Ucb4940   -   -   -   -   3件:
46,
97,
271 
 247   Ultracet   Acetaminophen   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   1件:
271 
 248   Upadacitinib   Upadacitinib   D10994   1件: JAK1   1件: JAK-STAT signaling pathway   6件:
41,
46,
49,
96,
97,
271 
 249   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 
 250   Voltaren resinat   -   -   -   -   1件:
271 
 251   Xeljanz   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   2件:
46,
271 
 252   Yisaipu®   -   -   -   -   1件:
271 

先頭へ